TY - JOUR
T1 - Sustained and expedited resolution of diabetic papillopathy with combined PRP and bevacizumab
AU - Chin, Eric K.
AU - Almeida, David R.P.
AU - Sohn, Elliott H.
PY - 2015/10
Y1 - 2015/10
KW - Intravitreal Injections
KW - Humans
KW - Bevacizumab/therapeutic use
KW - Combined Modality Therapy
KW - Laser Coagulation
KW - Diabetes Mellitus, Type 1/physiopathology
KW - Diabetic Neuropathies/drug therapy
KW - Young Adult
KW - Angiogenesis Inhibitors/therapeutic use
KW - Female
KW - Papilledema/drug therapy
KW - Vascular Endothelial Growth Factor A/antagonists & inhibitors
KW - Diabetic Retinopathy/drug therapy
KW - Fluorescein Angiography
UR - https://www.scopus.com/pages/publications/84944048934
UR - https://www.scopus.com/pages/publications/84944048934#tab=citedBy
UR - https://www.mendeley.com/catalogue/4f78e8b5-2ffa-376d-869c-10766dd7e8aa/
U2 - 10.1016/j.jcjo.2015.05.020
DO - 10.1016/j.jcjo.2015.05.020
M3 - Letter
C2 - 26455990
AN - SCOPUS:84944048934
SN - 0008-4182
VL - 50
SP - e88-e91
JO - Canadian Journal of Ophthalmology
JF - Canadian Journal of Ophthalmology
IS - 5
M1 - 794
ER -